ACQUISITION OF EFFECTIVE DETERMINATIONS FOR BLOOD CHEMISTRY AND IMMUNOLOGY FOR THE CLINICAL LABORATORY OF THE JOSÉ MARÍA VELASCO IBARRA GENERAL HOSPITAL OF TENA, YEAR 2026

This tender (Code: SIE-HGJMVI-2025-0047-15857) issued by the Hospital José María Velasco Ibarra General Hospital of Tena (HOSPITAL JOSE MARIA VELASCO IBARRA DE TENA) is for the acquisition of diagnostic tests for blood chemistry and immunology for the year 2026. The procurement method is an Electronic Reverse Auction. The required items are reagents for cellular analysis, with a quantity of 1 unit and an estimated value of USD 390,256.08. This acquisition is vital for the hospital's clinical laboratory, enabling comprehensive analysis of various biochemical and immunological parameters. These tests are fundamental for diagnosing a wide range of conditions, monitoring treatment efficacy, and assessing patient health status. Ensuring the availability of these diagnostic capabilities is essential for providing quality healthcare services and supporting clinical decision-making within the hospital.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.